Literature DB >> 6284789

Thyroid-stimulating hormone (TSH) receptor antibodies and antibodies stimulating adenyl cyclase in relatives from two families with a high prevalence of Graves' hyperthyroidism: a ten-year follow-up study.

J R Wall, C R Strakosch, M L Wellby, J Gooden, D Joyner, R Bayly.   

Abstract

Thyroid-stimulating hormone (TSH) receptor antibodies and antibodies stimulating adenyl cyclase were measured in 47 relatives of patients with Graves' hyperthyroidism from two families with a high prevalence of the disease, in whom bioassays for the long-acting thyroid stimulator (LATS) had been performed 10 years earlier. Tests were also carried out in six propositi from the two families and age- and sex-matched normal subjects from six families. There had been no new cases of hyperthyroidism since the first study, although one subject was clinically and biochemically hyperthyroid at the time of study and two more were biochemically borderline hyperthyroid but clinically euthyroid. Levels of serum T4 thyrotropin, and percentage T3 resin uptake and free thyroxine indices were similar for relatives and normal subjects, although the mean serum T3 level for relatives was significantly greater than that for the normal subjects. Antibodies were not detected by either assay in any relative. Significant titers of antithyroglobulin antibodies were demonstrated in 4 of 44 relatives but in none of 46 normals tested, while thyroid cytoplasmic antibodies were detected in 8 of 44 relatives and 3 of 45 normals. The mean serum IgG for Graves' relatives was significantly greater than that for the normals, although the mean IgM and IgA levels for the two groups were not significantly different.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6284789     DOI: 10.1007/bf00915973

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  27 in total

1.  The assessment of thyroid function by tracer tests with radioactive iodine.

Authors:  D D ADAMS; H D PURVES
Journal:  N Z Med J       Date:  1956-02

2.  The use of cryopreserved human thyroid tissue for the in vitro assay of thyroid stimulators.

Authors:  A J Knox; C von Westarp; V V Row; R Volpé
Journal:  Cryobiology       Date:  1977-10       Impact factor: 2.487

Review 3.  The pathogenesis of Graves' disease: an overview.

Authors:  R Volpé
Journal:  Clin Endocrinol Metab       Date:  1978-03

4.  Evidence for circulating immune complexes in thyroid disease.

Authors:  E A Calder; W J Penhale; E W Barnes; W J Irvine
Journal:  Br Med J       Date:  1974-04-06

5.  Thyroid-stimulating immunoglobulins in Graves' disease.

Authors:  B R Smith; R Hall
Journal:  Lancet       Date:  1974-08-24       Impact factor: 79.321

6.  Long-acting thyroid stimulator and thyroid function in relatives of patients with Graves' disease.

Authors:  M Bonnyns; L Vanhaerlst; J Golstein; C Cauchie; A M Ermans; P A Bastenie
Journal:  Clin Endocrinol (Oxf)       Date:  1973-07       Impact factor: 3.478

7.  Multi-system immunologically mediated disease: T lymphocyte deficiency and thyroid immunologic disease--a report of four cases.

Authors:  J R Wall; S L Fang; B A Walters; C R Strakosch; S H Ingbar; L E Braverman
Journal:  Aust N Z J Med       Date:  1978-06

8.  T, B and K cells in autoimmune thyroid disease.

Authors:  E A Calder; W J Irvine; N M Davidson; F Wu
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

9.  Thyroid-stimulating antibodies in patients with autoimmune disorders.

Authors:  C R Strakosch; D Joyner; J R Wall
Journal:  J Clin Endocrinol Metab       Date:  1978-08       Impact factor: 5.958

10.  Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody.

Authors:  A H COONS; M H KAPLAN
Journal:  J Exp Med       Date:  1950-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.